Crystalline polymorphic forms of an antidiabetic compound

The present invention relates to polymorphic forms of a compound of formula A: This compound is useful as a glucagon receptor antagonist and serves as a pharmaceutically active ingredient for the treatment of type 2 diabetes and related conditions, such as hyperglycemia, obesity, dyslipidemia, and t...

Full description

Saved in:
Bibliographic Details
Main Authors BAXTER JENNIFER, DESMOND DONAL, COTE AARON S, ZHANG YANFENG, CHUNG JOHN Y. L, ARTINO LAURA, VAYNSHTEYN YEKATERINA, SCOTT JEREMY
Format Patent
LanguageEnglish
Published 15.04.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to polymorphic forms of a compound of formula A: This compound is useful as a glucagon receptor antagonist and serves as a pharmaceutically active ingredient for the treatment of type 2 diabetes and related conditions, such as hyperglycemia, obesity, dyslipidemia, and the metabolic syndrome. Hydrates, hemihydrates, anhydrates and similar polymorphic forms are included.
Bibliography:Application Number: US201013144031